Oncology Institute Inc
NASDAQ:TOI
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.285
2.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Oncology Institute Inc
Oncology Institute Inc
Revenue
Oncology Institute Inc
Revenue Peer Comparison
UHS
EHC
THC
HCA
ENSG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncology Institute Inc
NASDAQ:TOI
|
Revenue
$324.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Revenue
$15.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Encompass Health Corp
NYSE:EHC
|
Revenue
$5.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Revenue
$20.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Revenue
$69.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Revenue
$4.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
Oncology Institute Inc
Revenue Breakdown
Breakdown by Geography
Oncology Institute Inc
Breakdown by Segments
Oncology Institute Inc
|
Total Revenue:
324.2m
USD
|
|
Health Care, Patient Service:
213.5m
USD
|
|
Fee For Service:
143.1m
USD
|
|
Dispensary Revenue:
103.8m
USD
|
|
Capitated Revenue:
70.4m
USD
|
|
Clinical Research Trials And Other Revenue:
6.9m
USD
|
See Also
What is Oncology Institute Inc's Revenue?
Revenue
324.2m
USD
Based on the financial report for Dec 31, 2023, Oncology Institute Inc's Revenue amounts to 324.2m USD.
What is Oncology Institute Inc's Revenue growth rate?
Revenue CAGR 5Y
23%
Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Oncology Institute Inc have been 20% over the past three years , 23% over the past five years .
You don't have any saved screeners yet
